Tumor Immunology and Immunotherapy

A deep dive into mechanisms of tumor immune evasion and the latest advances in immuno-oncology treatments.

Sub-topics:

• PD-1/PD-L1 checkpoint blockade: Resistance mechanisms & novel combinations
• CAR-T and CAR-NK cell therapies: Clinical outcomes and safety
• Tumor microenvironment (TME) reprogramming strategies
• Bispecific antibodies and next-gen immune engagers